I Farmaci Oncologici in Italia: innovazione e sostenibilità economica
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- repec:pri:cheawb:cutler_deaton_lleras-muney_determinants_mortality_nberdec05 is not listed on IDEAS
- Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010. "The productivity crisis in pharmaceutical R&D," Working Papers 06/2010, University of Verona, Department of Economics.
- Angus Deaton, 2003.
"Health, Inequality, and Economic Development,"
Journal of Economic Literature, American Economic Association, vol. 41(1), pages 113-158, March.
- Angus Deaton, 2001. "Health, Inequality, and Economic Development," NBER Working Papers 8318, National Bureau of Economic Research, Inc.
- Angus Deaton, 2002. "Health, inequality, and economic development," Working Papers 270, Princeton University, Woodrow Wilson School of Public and International Affairs, Center for Health and Wellbeing..
- Angus Deaton, 2002. "Health, inequality, and economic development," Working Papers 209, Princeton University, Woodrow Wilson School of Public and International Affairs, Research Program in Development Studies..
- Deaton, A., 2001. "Health, Inequality, and Economic Development," Papers 200, Princeton, Woodrow Wilson School - Development Studies.
- Angus Deaton, 2016. "Health, Inequality and Economic Development," Working Papers id:8791, eSocialSciences.
- Frank R. Lichtenberg, 2004.
"The Expanding Pharmaceutical Arsenal in the War on Cancer,"
NBER Working Papers
10328, National Bureau of Economic Research, Inc.
- Frank R. Lichtenberg, 2004. "The expanding pharmaceutical arsenal in the war on cancer," 2004 Meeting Papers 204, Society for Economic Dynamics.
- David Cutler & Angus Deaton & Adriana Lleras-Muney, 2006.
"The Determinants of Mortality,"
Journal of Economic Perspectives, American Economic Association, vol. 20(3), pages 97-120, Summer.
- David Cutler & Angus Deaton & Adriana Lleras-Muney, 2005. "The Determinants of Mortality," Working Papers 235, Princeton University, Woodrow Wilson School of Public and International Affairs, Center for Health and Wellbeing..
- David M. Cutler & Angus S. Deaton & Adriana Lleras-Muney, 2006. "The Determinants of Mortality," NBER Working Papers 11963, National Bureau of Economic Research, Inc.
- David Cutler & Angus Deaton & Adriana Lleras-Muney, 2005. "The Determinants of Mortality," Working Papers 164, Princeton University, Woodrow Wilson School of Public and International Affairs, Research Program in Development Studies..
- Cutler, David & Lleras-Muney, Adriana & Deaton, Angus, 2006. "The Determinants of Mortality," Scholarly Articles 2640588, Harvard University Department of Economics.
- David M. Cutler, 2006. "The Determinants of Mortality," Working Papers id:359, eSocialSciences.
- Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005.
"The Growth of Business Firms: Theoretical Framework and Empirical Evidence,"
MPRA Paper
15905, University Library of Munich, Germany.
- Dongfeng Fu & Fabio Pammolli & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," Papers physics/0512005, arXiv.org.
- Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(3), pages 1049-1090.
- Daron Acemoglu & Joshua Linn, 2003. "Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry," NBER Working Papers 10038, National Bureau of Economic Research, Inc.
- Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," Levine's Working Paper Archive 228400000000000002, David K. Levine.
- Massimo Riccaboni & Fabio Pammolli & Sergey V. Buldyrev & Linda Ponta & H. Eugene Stanley, 2009.
"The Size Variance Relationship of Business Firm Growth Rates,"
Papers
0904.1404, arXiv.org, revised Apr 2009.
- Massimo Riccaboni & Fabio Pammolli & Sergey V. Buldyrev & Linda Ponta & H. Eugene Stanley, 2009. "The Size Variance Relationship of Business Firm Growth Rates," ROCK Working Papers 052, Department of Computer and Management Sciences, University of Trento, Italy, revised 11 Jun 2009.
- Massimo Riccaboni & Fabio Pammolli & Sergey V. Buldyrev & Linda Ponta & H. Eugene Stanley, 2009. "The Size Variance Relationship of Business Firm Growth Rates," DISA Working Papers 0901, Department of Computer and Management Sciences, University of Trento, Italy, revised 11 Jun 2009.
- William D. Nordhaus, 2002.
"The Health of Nations: The Contribution of Improved Health to Living Standards,"
NBER Working Papers
8818, National Bureau of Economic Research, Inc.
- William D. Nordhaus, 2002. "The Health of Nations: The Contribution of Improved Health to Living Standards," Cowles Foundation Discussion Papers 1355, Cowles Foundation for Research in Economics, Yale University.
- Margaret K. Kyle, 2007. "Pharmaceutical Price Controls and Entry Strategies," The Review of Economics and Statistics, MIT Press, vol. 89(1), pages 88-99, February.
- Sergey V. Buldyrev & Jakub Growiec & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2007. "The Growth of Business Firms: Facts and Theory," Journal of the European Economic Association, MIT Press, vol. 5(2-3), pages 574-584, 04-05.
- repec:pri:rpdevs:cutler_deaton_lleras-muney_determinants_mortality_nberdec05 is not listed on IDEAS
- repec:pri:rpdevs:cutler_deaton_lleras-muney_determinants_mortality_nberdec05.pdf is not listed on IDEAS
- Carol Corrado & John Haltiwanger & Daniel Sichel, 2005. "Measuring Capital in the New Economy," NBER Books, National Bureau of Economic Research, Inc, number corr05-1, March.
- Stefano Capri & Rossella Levaggi, 2010. "Shifting the risk in pricing and reimbursement schemes. A new model of risk-sharing agreements for innovative drugs," LIUC Papers in Economics 234, Cattaneo University (LIUC).
- Lou Garrison;Ruth Puig-Peiro;Adrian Towse, 2012. "The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?," Occasional Paper 000167, Office of Health Economics.
- Gérard Pouvourville, 2006. "Risk-sharing agreements for innovative drugs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(3), pages 155-157, September.
- Davide Integlia & Fabio Pammolli, 2009. "I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini," Working Papers CERM 01-2009, Competitività, Regole, Mercati (CERM).
- repec:pri:cheawb:cutler_deaton_lleras-muney_determinants_mortality_nberdec05.pdf is not listed on IDEAS
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
- Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020.
"Innovation and Corporate Dynamics: A Theoretical Framework,"
Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 12(1), pages 1-45, March.
- Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," DISA Working Papers 2011/08, Department of Computer and Management Sciences, University of Trento, Italy, revised 29 Jul 2011.
- Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
- Rosella Levaggi & Michele Moretto & Paolo Pertile, 2017.
"The Dynamics of Pharmaceutical Regulation and R&D Investments,"
Journal of Public Economic Theory, Association for Public Economic Theory, vol. 19(1), pages 121-141, February.
- Rosella Levaggi & Michele Moretto & Paolo Pertile, 2013. "The dynamics of pharmaceutical regulation and R&D investments," Working Papers 13/2013, University of Verona, Department of Economics.
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016.
"Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry,"
RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Olatunji A. Shobande & Lawrence Ogbeifun & Simplice A. Asongu, 2022.
"Globalisation, technology and global health,"
Working Papers of the African Governance and Development Institute.
22/070, African Governance and Development Institute..
- Olatunji A. Shobande & Lawrence Ogbeifun & Simplice A. Asongu, 2022. "Globalisation, technology and global health," Working Papers 22/070, European Xtramile Centre of African Studies (EXCAS).
- Massimo Riccaboni & Stefano Schiavo, 2009.
"The Structure and Growth of International Trade,"
Documents de Travail de l'OFCE
2009-24, Observatoire Francais des Conjonctures Economiques (OFCE).
- Massimo Riccaboni & Stefano Schiavo, 2010. "The Structure and Growth of International Trade," DEGIT Conference Papers c015_032, DEGIT, Dynamics, Economic Growth, and International Trade.
- Massimo Riccaboni & Stefano Schiavo, 2010. "The Structure and Growth of International Trade," Department of Economics Working Papers 1005, Department of Economics, University of Trento, Italia.
- Massimo Riccaboni & Stefano Schiavo, 2009. "The Structure and Growth of Weighted Networks," Papers 0908.0348, arXiv.org, revised Dec 2009.
- Jobjörnsson, Sebastian & Forster, Martin & Pertile, Paolo & Burman, Carl-Fredrik, 2016.
"Late-stage pharmaceutical R&D and pricing policies under two-stage regulation,"
Journal of Health Economics, Elsevier, vol. 50(C), pages 298-311.
- Sebastian Jobjornsson & Martin Forster & Paolo Pertile & Carl-Fredrik Burman, 2015. "Late-Stage Pharmaceutical R & D and Pricing Policies under Two-Stage Regulation," Discussion Papers 15/16, Department of Economics, University of York.
- Misako Takayasu & Hayafumi Watanabe & Hideki Takayasu, 2013. "Generalised central limit theorems for growth rate distribution of complex systems," Papers 1301.2728, arXiv.org, revised Jan 2014.
- Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
- Xie, Wen-Jie & Gu, Gao-Feng & Zhou, Wei-Xing, 2010. "On the growth of primary industry and population of China’s counties," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 389(18), pages 3876-3882.
- Fraser Summerfield & Livio Di Matteo, 2021. "Influenza Pandemics and Macroeconomic Fluctuations in Recent Economic History," Working Papers 210002, Canadian Centre for Health Economics.
- Lionel Kesztenbaum & Jean-Laurent Rosenthal, 2014.
"Income versus Sanitation; Mortality Decline in Paris, 1880-1914,"
PSE Working Papers
halshs-01018594, HAL.
- Lionel Kesztenbaum & Jean-Laurent Rosenthal, 2014. "Income versus Sanitation; Mortality Decline in Paris, 1880-1914," Working Papers halshs-01018594, HAL.
- Vellore Arthi & James Fenske, 2018. "Polygamy and child mortality: Historical and modern evidence from Nigeria’s Igbo," Review of Economics of the Household, Springer, vol. 16(1), pages 97-141, March.
- Chiara Criscuolo & Angelo Secchi, 2016.
"Resources (mis)allocation, innovation and the competitiveness of Europe,"
Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 43(1), pages 1-9, March.
- Chiara Criscuolo & Angelo Secchi, 2016. "Resources (mis)allocation, innovation and the competitiveness of Europe," Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 43(1), pages 1-9, March.
- Pierre Dubois & Morten Sæthre, 2020.
"On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector,"
Econometrica, Econometric Society, vol. 88(6), pages 2503-2545, November.
- Dubois, Pierre & Sæthre, Morten, 2017. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," Discussion Paper Series in Economics 3/2018, Norwegian School of Economics, Department of Economics.
- Pierre Dubois & Morten Sæthre, 2020. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," Post-Print hal-03176406, HAL.
- Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," TSE Working Papers 18-883, Toulouse School of Economics (TSE), revised Mar 2020.
- Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector," CEPR Discussion Papers 12649, C.E.P.R. Discussion Papers.
- Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016.
"Patents and the Global Diffusion of New Drugs,"
American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
- Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
- Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
- Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
- Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
- Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
- Stephen Knowles & P. Dorian Owen, 2010.
"Which Institutions are Good for Your Health? The Deep Determinants of Comparative Cross-country Health Status,"
Journal of Development Studies, Taylor & Francis Journals, vol. 46(4), pages 701-723.
- P. Dorian Owen & Stephen Knowles, 2008. "Which Institutions are Good for Your Health? The Deep Determinants of Comparative Cross-country Health Status," Working Papers 0811, University of Otago, Department of Economics, revised Dec 2008.
- Duclos, Jean-Yves & Échevin, Damien, 2011.
"Health and income: A robust comparison of Canada and the US,"
Journal of Health Economics, Elsevier, vol. 30(2), pages 293-302, March.
- Jean-Yves Duclos & Damien Echevin, 2008. "Health and income: A robust comparison of Canada and the US," Cahiers de recherche 08-08, Departement d'économique de l'École de gestion à l'Université de Sherbrooke.
- Jean-Yves Duclos & Damien Échevin, 2015. "Health and income: A robust comparison of Canada and the US," Working Papers 378, Barcelona School of Economics.
- Duclos, Jean-Yves & Échevin, Damien, 2009. "Health and Income: A Robust Comparison of Canada and the US," IZA Discussion Papers 4506, Institute of Labor Economics (IZA).
- Jean-Yves Duclos & Damien Échevin, 2009. "Health and Income: a Robust Comparison of Canada and the US," Cahiers de recherche 0909, CIRPEE.
- Jean-Yves Duclos & Damien Échevin, 2009. "Health and Income: A Robust Comparison of Canada and the US," UFAE and IAE Working Papers 768.09, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
- Hannes Schwandt, 2018.
"Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations,"
American Economic Journal: Applied Economics, American Economic Association, vol. 10(4), pages 349-377, October.
- Schwandt, Hannes, 2014. "Wealth shocks and health outcomes: evidence from stock market fluctuations," LSE Research Online Documents on Economics 60352, London School of Economics and Political Science, LSE Library.
- Schwandt, Hannes, 2018. "Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations," CEPR Discussion Papers 12562, C.E.P.R. Discussion Papers.
- Hannes Schwandt, 2014. "Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations," CEP Discussion Papers dp1281, Centre for Economic Performance, LSE.
- Schwandt, Hannes, 2014. "Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations," IZA Discussion Papers 8298, Institute of Labor Economics (IZA).
More about this item
Keywords
farmaci oncologici; sanità; sostenibilità;All these keywords.
JEL classification:
- D40 - Microeconomics - - Market Structure, Pricing, and Design - - - General
- H50 - Public Economics - - National Government Expenditures and Related Policies - - - General
- H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
- H70 - Public Economics - - State and Local Government; Intergovernmental Relations - - - General
- H75 - Public Economics - - State and Local Government; Intergovernmental Relations - - - State and Local Government: Health, Education, and Welfare
- H77 - Public Economics - - State and Local Government; Intergovernmental Relations - - - Intergovernmental Relations; Federalism
- I0 - Health, Education, and Welfare - - General
- I10 - Health, Education, and Welfare - - Health - - - General
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ern:wpaper:02-2012. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Guido Bora` (email available below). General contact details of provider: https://edirc.repec.org/data/cermmit.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.